{
  "abstract": "Ferroptosis holds significant promise for cancer therapeutics. While inhibition of glutathione peroxidase 4 (GPX4), a central intrinsic defense against ferroptosis, is sufficient to induce this process in cancer cells, the scarcity of bioavailable GPX4 inhibitors has hindered both mechanistic studies in vivo and therapeutic exploration. Furthermore, the absence of a well-defined ligand-binding pocket and the high intrinsic reactivity of traditional covalent chemotypes complicate inhibitor optimization. Inspired by the SN2-like geometry of the oxidative step in GPX4 catalysis, we developed a heterobenzylic isourea as a tunable leaving group for covalent GPX4 inhibitor design. Systematic variation of the isourea substituent, heteroaromatic scaffold, conformational rigidity, distal side chain, and stereochemistry established comprehensive structure–activity relationships. A key intermediate, compound 100, confirmed on-target ferroptotic activity by inducing lipid peroxidation and liproxstatin-1-rescuable cytotoxicity across cancer cell lines, while an alkyne-tagged analogue enabled cellular GPX4 target enrichment. Further optimization delivered two complementary, orally bioavailable leads. Compound 418 is a potent cellular probe (IC50 = 7.7 nM), whereas compound 380 combines the lowest systemic clearance among the series in mice together with dose-proportional oral exposure. Oral administration of compound 380 suppresses tumor growth in both 786-O and MDA-MB-468 xenografts. [1H,15N]-HSQC measurements support enhanced GPX4–ligand interaction under dodecylphosphocholine (DPC) membrane-mimetic conditions. Beyond defining the medicinal-chemistry characteristics of this isourea compound series, our work establishes non-retained leaving-group engineering as a strategy for developing covalent GPX4 inhibitors with tunable cellular and pharmacokinetic properties.",
  "abstract_shown": true,
  "affiliations": [
    "Fudan University Shanghai 200433 China",
    "School of Life Sciences, Westlake University Hangzhou 310024 Zhejiang China",
    "Keen Therapeutics, Co., Ltd. Suzhou 215000 China",
    "Department of Chemistry, School of Science, Westlake University Hangzhou 310024 Zhejiang China"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 31,
  "authors": [
    {
      "affs": [
        0,
        1
      ],
      "name": "Yang Lu"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Zijian Pan"
    },
    {
      "affs": [
        2
      ],
      "name": "Lijie Bai"
    },
    {
      "affs": [
        2
      ],
      "name": "Senhao Xiao"
    },
    {
      "affs": [
        1
      ],
      "name": "Xin Gu"
    },
    {
      "affs": [
        1
      ],
      "name": "Jiayu Li"
    },
    {
      "affs": [
        2
      ],
      "name": "Weihua Shi"
    },
    {
      "affs": [
        2
      ],
      "name": "Xiaoxiao Zhang"
    },
    {
      "affs": [
        2
      ],
      "name": "Shi’en Liu"
    },
    {
      "affs": [
        2
      ],
      "name": "Chong Lu"
    },
    {
      "affs": [
        2
      ],
      "name": "Zhou Zhou"
    },
    {
      "affs": [
        2
      ],
      "name": "Rongsheng Ma"
    },
    {
      "affs": [
        2
      ],
      "name": "Yingqiang Xu"
    },
    {
      "affs": [
        2
      ],
      "name": "Qianli Tan"
    },
    {
      "affs": [
        2
      ],
      "name": "Hong’e Qu"
    },
    {
      "affs": [
        2
      ],
      "name": "Die Hu"
    },
    {
      "affs": [
        2
      ],
      "name": "Bolin Liu"
    },
    {
      "affs": [
        2
      ],
      "name": "Lili Fan"
    },
    {
      "affs": [
        2
      ],
      "name": "Hongqing Yao"
    },
    {
      "affs": [
        2
      ],
      "name": "Zhiwen Chen"
    },
    {
      "affs": [
        2
      ],
      "name": "Weiwei Fan"
    },
    {
      "affs": [
        2
      ],
      "name": "Qiwen Qian"
    },
    {
      "affs": [
        2
      ],
      "name": "Jun Cao"
    },
    {
      "affs": [
        2
      ],
      "name": "Wu Hou"
    },
    {
      "affs": [
        2
      ],
      "name": "Qiu Li"
    },
    {
      "affs": [
        2
      ],
      "name": "Caiyi Wei"
    },
    {
      "affs": [
        2
      ],
      "name": "Wenqin Zeng"
    },
    {
      "affs": [
        1
      ],
      "name": "Nathchar Naowarojna"
    },
    {
      "affs": [
        2
      ],
      "name": "Jun Yu",
      "orcid": "0000-0001-5507-0303"
    },
    {
      "affs": [
        2
      ],
      "name": "Yikai Wang"
    },
    {
      "affs": [
        1,
        3
      ],
      "name": "Yilong Zou",
      "orcid": "0000-0001-8198-6067"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/fk55kawwn9hwk.bib",
  "cited_by": 0,
  "doi": "10.1039/d6cb00321d",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13758398/",
  "id": "fk55kawwn9hwk",
  "issns": [
    "2633-0679"
  ],
  "landing_url": "https://doi.org/10.1039/d6cb00321d",
  "language": "en",
  "licence": "CC-BY-NC-3.0",
  "licence_label": "CC BY-NC 3.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc/3.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Chemistry"
    ],
    [
      "openalex",
      "1306|Ferroptosis and cancer prognosis"
    ]
  ],
  "openalex": "W7225916458",
  "pdf_url": "https://pubs.rsc.org/cb/article-pdf/doi/10.1039/d6cb00321d/15086019/d6cb00321d.pdf",
  "pmcid": "PMC13758398",
  "pmid": "43023136",
  "published": "2026-11-12",
  "publisher": "Royal Society of Chemistry",
  "ris": "https://research.draconitic.com/paper/fk55kawwn9hwk.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:23:32Z",
      "native_id": "PMC13758398",
      "source": "pmc",
      "url": "https://doi.org/10.1039/d6cb00321d"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:1306|Ferroptosis and cancer prognosis",
      "subfield": "oncology"
    }
  ],
  "title": "Development of isourea-based covalent GPX4 inhibitors and structure–activity relationship analysis in ferroptosis induction",
  "title_text": "Development of isourea-based covalent GPX4 inhibitors and structure–activity relationship analysis in ferroptosis induction",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:23:32Z",
  "url": "https://research.draconitic.com/paper/fk55kawwn9hwk",
  "venue": "RSC Chemical Biology",
  "versions": []
}